244 related articles for article (PubMed ID: 19414339)
21. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.
Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V
Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of 2-methacryloyloxyethyl phosphorylcholine polymeric nanoparticle for immunoassay of C-reactive protein detection.
Park J; Kurosawa S; Watanabe J; Ishihara K
Anal Chem; 2004 May; 76(9):2649-55. PubMed ID: 15117211
[TBL] [Abstract][Full Text] [Related]
23. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
Tseng CL; Su WY; Yen KC; Yang KC; Lin FH
Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990
[TBL] [Abstract][Full Text] [Related]
24. EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice.
Shir A; Ogris M; Wagner E; Levitzki A
PLoS Med; 2006 Jan; 3(1):e6. PubMed ID: 16318410
[TBL] [Abstract][Full Text] [Related]
25. Photodynamic therapy using an anti-EGF receptor antibody complexed with verteporfin nanoparticles: a proof of concept study.
Kameyama N; Matsuda S; Itano O; Ito A; Konno T; Arai T; Ishihara K; Ueda M; Kitagawa Y
Cancer Biother Radiopharm; 2011 Dec; 26(6):697-704. PubMed ID: 21861705
[TBL] [Abstract][Full Text] [Related]
26. The cytotoxicity of a conjugate composed of human epidermal growth factor and eosinophil cationic protein.
Jinno H; Ueda M; Ozawa S; Ikeda T; Kitajima M; Maeda T; Seno M
Anticancer Res; 2002; 22(6C):4141-5. PubMed ID: 12553045
[TBL] [Abstract][Full Text] [Related]
27. PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy.
Yoshizawa Y; Kono Y; Ogawara K; Kimura T; Higaki K
Int J Pharm; 2011 Jun; 412(1-2):132-41. PubMed ID: 21507344
[TBL] [Abstract][Full Text] [Related]
28. 131I-recombinant human EGF has antitumor effects against MCF-7 human breast cancer xenografts with low levels of EGFR.
Li YC; Xu WY; Tan TZ; He S
Nucl Med Biol; 2004 May; 31(4):435-40. PubMed ID: 15093813
[TBL] [Abstract][Full Text] [Related]
29. pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice.
Dalela M; Shrivastav TG; Kharbanda S; Singh H
ACS Appl Mater Interfaces; 2015 Dec; 7(48):26530-48. PubMed ID: 26528585
[TBL] [Abstract][Full Text] [Related]
30. Apoptotic epidermal growth factor (EGF)-conjugated block copolymer micelles as a nanotechnology platform for targeted combination therapy.
Lee H; Hu M; Reilly RM; Allen C
Mol Pharm; 2007; 4(5):769-81. PubMed ID: 17867644
[TBL] [Abstract][Full Text] [Related]
31. Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy.
Mugabe C; Hadaschik BA; Kainthan RK; Brooks DE; So AI; Gleave ME; Burt HM
BJU Int; 2009 Apr; 103(7):978-86. PubMed ID: 19007363
[TBL] [Abstract][Full Text] [Related]
32. In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles.
Letchford K; Liggins R; Wasan KM; Burt H
Eur J Pharm Biopharm; 2009 Feb; 71(2):196-206. PubMed ID: 18762253
[TBL] [Abstract][Full Text] [Related]
33. Intratumoral delivery of paclitaxel using a thermosensitive hydrogel in human tumor xenografts.
Kim JH; Lee JH; Kim KS; Na K; Song SC; Lee J; Kuh HJ
Arch Pharm Res; 2013 Jan; 36(1):94-101. PubMed ID: 23371803
[TBL] [Abstract][Full Text] [Related]
34. Anti-tumor activity of paclitaxel through dual-targeting lipoprotein-mimicking nanocarrier.
Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Chen D
J Drug Target; 2015 May; 23(4):311-22. PubMed ID: 25539074
[TBL] [Abstract][Full Text] [Related]
35. In vivo and in vitro anti-cancer activities and enhanced cellular uptakes of EGF fragment decorated doxorubicin nano-aggregates.
Park S; Yoo HS
Int J Pharm; 2010 Jan; 383(1-2):178-85. PubMed ID: 19732814
[TBL] [Abstract][Full Text] [Related]
36. Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier.
Mooberry LK; Nair M; Paranjape S; McConathy WJ; Lacko AG
J Drug Target; 2010 Jan; 18(1):53-8. PubMed ID: 19637935
[TBL] [Abstract][Full Text] [Related]
37. Photochemically enhanced transduction of polymer-complexed adenovirus targeted to the epidermal growth factor receptor.
Bonsted A; Engesaeter BØ; Høgset A; Maelandsmo GM; Prasmickaite L; D'Oliveira C; Hennink WE; van Steenis JH; Berg K
J Gene Med; 2006 Mar; 8(3):286-97. PubMed ID: 16342300
[TBL] [Abstract][Full Text] [Related]
38. Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice.
Knight V; Koshkina NV; Golunski E; Roberts LE; Gilbert BE
Trans Am Clin Climatol Assoc; 2004; 115():395-404; discussion 404. PubMed ID: 17060982
[TBL] [Abstract][Full Text] [Related]
39. Functionalized nanospheres for targeted delivery of paclitaxel.
Bushman J; Vaughan A; Sheihet L; Zhang Z; Costache M; Kohn J
J Control Release; 2013 Nov; 171(3):315-21. PubMed ID: 23792807
[TBL] [Abstract][Full Text] [Related]
40. Epidermal growth factor-ferritin H-chain protein nanoparticles for tumor active targeting.
Li X; Qiu L; Zhu P; Tao X; Imanaka T; Zhao J; Huang Y; Tu Y; Cao X
Small; 2012 Aug; 8(16):2505-14. PubMed ID: 22619186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
